PDCD1 and neoplasm: Tumor establishment and progression involve the proliferation of hypo-immunogenic cells that manage to evade the immune system by exploiting immune checkpoints, such as the programed cell death 1 (PD1) PD-ligand 1 (PDL1) axis and cytotoxic T lymphocyte antigen-4 (CTLA-4) [1].